Matches in SemOpenAlex for { <https://semopenalex.org/work/W2586536698> ?p ?o ?g. }
- W2586536698 endingPage "846" @default.
- W2586536698 startingPage "835" @default.
- W2586536698 abstract "Cisplatin treatment some times leads to chemoresistance, which is now acknowledged partially due to the inductive expression of progesterone receptor membrane component (PGRMC)1 in ovarian cancer cells. PGRMC1 enhances autophagy, activates cytochrome p450, and inveigles signaling pathways to promote cell survival and reduce the effect of drug treatments. In this study, we give first line evidence that hyperoside inhibits cell viability, triggers autophagy and apoptosis in ovarian cancer cell lines. Mechanistically, PGRMC1-dependent autophagy was utilized by hyperoside to induce apoptotic cell death. Hyperoside induced the conversion of LC3B-I to LC3B-II and the formation of autophagosomes in ovarian cancer cells. Notably, PGRMC1 colocolized with LC3B‑II, and PGRMC1 overexpression enhanced hyperoside-induced autophagy and apoptosis, while PGRMC1 knockdown abrogated the action. Additionally, AKT signaling and Bcl-2 family were also involved in the hyperoside-induced autophagy and apoptosis. Importantly, in cisplatin-resistant ovarian cancer cells where PGRMC1 was overexpressed, hyperoside sensitized the cells to cisplatin treatment. Together these findings indicate hyperoside functions as a complementary therapy for ovarian cancer patients receiving platinum-based therapy." @default.
- W2586536698 created "2017-02-17" @default.
- W2586536698 creator A5007461062 @default.
- W2586536698 creator A5012896256 @default.
- W2586536698 creator A5013205564 @default.
- W2586536698 creator A5015661586 @default.
- W2586536698 creator A5029262470 @default.
- W2586536698 creator A5040987305 @default.
- W2586536698 creator A5078825784 @default.
- W2586536698 creator A5082016315 @default.
- W2586536698 date "2017-02-10" @default.
- W2586536698 modified "2023-10-01" @default.
- W2586536698 title "PGRMC1-dependent autophagy by hyperoside induces apoptosis and sensitizes ovarian cancer cells to cisplatin treatment" @default.
- W2586536698 cites W1570925259 @default.
- W2586536698 cites W1972628924 @default.
- W2586536698 cites W1978520932 @default.
- W2586536698 cites W2000516637 @default.
- W2586536698 cites W2002358638 @default.
- W2586536698 cites W2011580247 @default.
- W2586536698 cites W2015716689 @default.
- W2586536698 cites W2023309489 @default.
- W2586536698 cites W2034786597 @default.
- W2586536698 cites W2035119142 @default.
- W2586536698 cites W2037001538 @default.
- W2586536698 cites W2038466882 @default.
- W2586536698 cites W2041943889 @default.
- W2586536698 cites W2047938253 @default.
- W2586536698 cites W2050656013 @default.
- W2586536698 cites W2050837091 @default.
- W2586536698 cites W2054239953 @default.
- W2586536698 cites W2059388879 @default.
- W2586536698 cites W2066112158 @default.
- W2586536698 cites W2067465277 @default.
- W2586536698 cites W2077397852 @default.
- W2586536698 cites W2077418979 @default.
- W2586536698 cites W2078911476 @default.
- W2586536698 cites W2082796078 @default.
- W2586536698 cites W2085858083 @default.
- W2586536698 cites W2090573853 @default.
- W2586536698 cites W2095135239 @default.
- W2586536698 cites W2097331409 @default.
- W2586536698 cites W2098567606 @default.
- W2586536698 cites W2106255061 @default.
- W2586536698 cites W2110258724 @default.
- W2586536698 cites W2114742782 @default.
- W2586536698 cites W2141452671 @default.
- W2586536698 cites W2142120946 @default.
- W2586536698 cites W2143533174 @default.
- W2586536698 cites W2155837467 @default.
- W2586536698 cites W2165424593 @default.
- W2586536698 cites W2169003271 @default.
- W2586536698 cites W2171069693 @default.
- W2586536698 cites W2278629103 @default.
- W2586536698 cites W2296998275 @default.
- W2586536698 cites W2365533528 @default.
- W2586536698 cites W2397077488 @default.
- W2586536698 cites W2425010760 @default.
- W2586536698 cites W2492142928 @default.
- W2586536698 cites W4297244442 @default.
- W2586536698 doi "https://doi.org/10.3892/ijo.2017.3873" @default.
- W2586536698 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28197632" @default.
- W2586536698 hasPublicationYear "2017" @default.
- W2586536698 type Work @default.
- W2586536698 sameAs 2586536698 @default.
- W2586536698 citedByCount "40" @default.
- W2586536698 countsByYear W25865366982017 @default.
- W2586536698 countsByYear W25865366982018 @default.
- W2586536698 countsByYear W25865366982019 @default.
- W2586536698 countsByYear W25865366982020 @default.
- W2586536698 countsByYear W25865366982021 @default.
- W2586536698 countsByYear W25865366982022 @default.
- W2586536698 countsByYear W25865366982023 @default.
- W2586536698 crossrefType "journal-article" @default.
- W2586536698 hasAuthorship W2586536698A5007461062 @default.
- W2586536698 hasAuthorship W2586536698A5012896256 @default.
- W2586536698 hasAuthorship W2586536698A5013205564 @default.
- W2586536698 hasAuthorship W2586536698A5015661586 @default.
- W2586536698 hasAuthorship W2586536698A5029262470 @default.
- W2586536698 hasAuthorship W2586536698A5040987305 @default.
- W2586536698 hasAuthorship W2586536698A5078825784 @default.
- W2586536698 hasAuthorship W2586536698A5082016315 @default.
- W2586536698 hasBestOaLocation W25865366981 @default.
- W2586536698 hasConcept C121608353 @default.
- W2586536698 hasConcept C190283241 @default.
- W2586536698 hasConcept C203522944 @default.
- W2586536698 hasConcept C2775963812 @default.
- W2586536698 hasConcept C2776586676 @default.
- W2586536698 hasConcept C2776694085 @default.
- W2586536698 hasConcept C2778004101 @default.
- W2586536698 hasConcept C2778239845 @default.
- W2586536698 hasConcept C2780427987 @default.
- W2586536698 hasConcept C31573885 @default.
- W2586536698 hasConcept C502942594 @default.
- W2586536698 hasConcept C54355233 @default.
- W2586536698 hasConcept C55493867 @default.
- W2586536698 hasConcept C86803240 @default.
- W2586536698 hasConcept C95444343 @default.
- W2586536698 hasConcept C96232424 @default.